Change in Patient-Reported Outcomes in Severe Eosinophilic Asthma Patients Treated With Benralizumab Under Real-life Conditions
Clinical trial NCT04184284 · COMPLETED
Trial details
- NCT number
- NCT04184284
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-11-15
- Primary completion
- 2023-12-19
- Enrollment
- 246
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.